HIGHLIGHTS
- who: Tirado Mercier E and colleagues from the Chemotherapy Treatment in Spain have published the research: Journal of Health Economics and Outcomes Research, in the Journal: (JOURNAL)
- what: Design and methods: A Markov model was developed to compare radium-223 versus BSC and to accrue the health outcomes and costs of a simulated cohort of mCRPC patients. The aim of this paper is to assess the cost-effectiveness of radium-223 compared with BSC in a population of patients with mCRPC who were previously treated with docetaxel in Spain. To extrapolate the treatment efficacy observed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.